Stock Performance and Market Context
On 24 Nov 2025, Acutaas Chemicals recorded an intraday peak of Rs 1901.35, representing an 11.8% rise during the trading session. This performance notably outpaced its sector by 11.54%, underscoring the stock’s relative strength in a day when the broader Sensex index experienced a decline of 0.39%, closing at 84,900.71 points. Despite the Sensex opening higher by 88.12 points, it retreated by 419.33 points during the day, remaining 1.06% shy of its own 52-week high of 85,801.70.
Acutaas Chemicals is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained upward momentum. This technical positioning often indicates positive investor sentiment and a strong trend in price movement.
Long-Term Growth and Financial Metrics
Over the past year, Acutaas Chemicals has demonstrated substantial growth, with its stock price appreciating by 79.36%, significantly outperforming the Sensex’s 7.31% gain over the same period. The company’s 52-week low was Rs 919.63, highlighting the considerable price appreciation within the last twelve months.
Financially, the company has exhibited healthy expansion in net sales and profitability. Net sales for the latest six months stood at Rs 513.44 crores, reflecting a growth rate of 21.27%. Operating profit has shown an annual growth rate of 32.44%, while net profit has expanded by 63.28%, indicating strong earnings momentum. These figures are supported by a return on capital employed (ROCE) of 21.30% for the half-year period, which is a robust indicator of efficient capital utilisation.
Inventory turnover ratio for the half-year is at 5.74 times, suggesting effective management of stock levels relative to sales. The company’s debt-to-equity ratio remains at zero, indicating a conservative capital structure with no reliance on debt financing, which can be favourable in volatile market conditions.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Institutional Holdings and Market Position
Institutional investors hold a significant stake in Acutaas Chemicals, accounting for 39.44% of the shareholding. This level of institutional participation often reflects confidence in the company’s fundamentals and long-term prospects. The stock has consistently delivered returns over the last three years, outperforming the BSE500 index in each annual period, which highlights its resilience and steady performance within the broader market.
Valuation and Profitability Considerations
Acutaas Chemicals reports a return on equity (ROE) of 15.8%, which is a key measure of profitability relative to shareholder equity. The stock’s price-to-book value stands at 9.8, indicating a premium valuation compared to its book value. Despite this, the stock trades at a discount relative to its peers’ average historical valuations, suggesting a nuanced valuation landscape.
Profit growth over the past year has been notable at 139.8%, while the price appreciation of 79.36% during the same period results in a price/earnings to growth (PEG) ratio of 0.5. This metric can be interpreted as the stock’s earnings growth outpacing its price increase, a factor that some market participants may consider when analysing valuation.
Want to dive deeper on Acutaas Chemicals ? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Sector and Industry Context
Operating within the Pharmaceuticals & Biotechnology sector, Acutaas Chemicals’ performance stands out amid a market environment where the broader indices have shown mixed signals. The sector itself is characterised by innovation and regulatory dynamics, which can influence stock performance. Acutaas Chemicals’ ability to maintain upward price momentum and deliver consistent financial results over multiple quarters reflects its operational strength within this competitive landscape.
Summary of Key Price and Performance Metrics
To summarise, Acutaas Chemicals’ stock price reached Rs 1901.35 today, marking a new 52-week high. The stock’s performance today outpaced its sector by 11.54%, and it remains well above all major moving averages, signalling sustained positive momentum. Over the last year, the stock has appreciated by 79.36%, significantly outperforming the Sensex benchmark. Financial indicators such as net sales growth, operating profit expansion, and net profit increase further underpin the stock’s recent price action.
While the broader market indices have experienced some volatility, Acutaas Chemicals’ trajectory highlights its distinct position within the Pharmaceuticals & Biotechnology sector. The company’s conservative capital structure, strong institutional backing, and consistent quarterly results contribute to the stock’s current valuation and market standing.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
